Servier launches U.S. cancer business with plans to double headcount in next 5 years

France ’s second-largest pharmaceutical company, Servier Group, opened its first U.S.-based commercial subsidiary in Boston this week, with plans to double the headcount over the next five years. Servier Pharmaceuticals opened its doors at 200 Pier 4 Blvd. Thursday. The 14,500-square-foot site will hous e Servier's work developing and commercializing treatments for gastrointestinal and liquid cancers like leukemia using immune system-leveraging approaches including CAR-T and monoclonal antibodies.…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news